NYSE:CIHealthcare
A Look At Cigna Group (CI) Valuation As Guidance Rises And Rebate Free Pharmacy Launches
Cigna Group (CI) is back in focus after recent quarterly results and investor presentations highlighted a simplified healthcare process, a new rebate free pharmacy service, and higher 2026 adjusted earnings guidance.
See our latest analysis for Cigna Group.
The recent guidance upgrade and conference appearances come after a mixed stretch for the stock, with a 30 day share price return of 2.38% but a 1 year total shareholder return that declined 9.52%. Over the 3 and 5 year periods, total...